文献速递主动脉疾病

一种新型术前风险评估工具用于识别腹主动脉瘤腔内修复术后对比剂相关急性肾损伤风险患者

A Novel Preoperative Risk Assessment Tool to Identify Patients at Risk of Contrast-Associated Acute Kidney Injury After Endovascular Abdominal Aortic Aneurysm Repair.
PubMed 文献 · Ann Vasc Surg · 2023-03-01

研究基于密歇根蓝十字蓝盾心血管联盟数据库构建并验证择期EVAR术后CA-AKI的术前风险分层工具。推导队列7043例中3.5%发生CA-AKI,筛选出年龄、女性、GFR<30 mL/min、当前吸烟、COPD、最大AAA直径及髂动脉瘤等预测变量。在Vascular Quality Initiative数据集62986例中验证GFR<30 mL/min、女性及最大AAA直径>6.9 cm与CA-AKI风险增加相关。

要点

  • 推导队列7043例中3.5%发生CA-AKI,多因素分析筛选出7个预测变量。
  • 预测计算器显示GFR<30 mL/min、女性及最大AAA直径>6.9 cm者CA-AKI风险更高。
  • 验证队列62986例中GFR<30 mL/min、女性及最大AAA直径>6.9 cm与CA-AKI风险增加相关。

核心结论

  • 作者提出一种简单的术前风险评估工具,可用于识别EVAR术后CA-AKI风险患者。
  • 作者认为GFR<30 mL/min、最大AAA直径>6.9 cm及女性接受EVAR者可能存在CA-AKI风险。
  • 作者指出需前瞻性研究确定该模型的效能。

研究设计与样本

  • 研究查询密歇根蓝十字蓝盾心血管联盟数据库中的择期EVAR患者,排除透析、肾移植史、术中死亡及无肌酐测量者。
  • 采用混合效应逻辑回归检验与CA-AKI(肌酐升高>0.5 mg/dL)的关联,并通过单分类树生成预测模型。
  • 将分类树选择的变量在Vascular Quality Initiative数据集中通过拟合混合效应逻辑回归模型进行验证。

主要发现

  • 推导队列纳入7043例患者,其中3.5%发生CA-AKI。
  • 多因素分析显示年龄(OR 1.021,95%CI 1.004-1.040)、女性(OR 1.393,95%CI 1.012-1.916)、GFR<30 mL/min(OR 5.068,95%CI 3.255-7.891)、当前吸烟(OR 1.942,95%CI 1.067-3.535)、COPD(OR 1.402,95%CI 1.066-1.843)、最大AAA直径(OR 1.018,95%CI 1.006-1.029)及髂动脉瘤存在(OR 1.352,95%CI 1.007-1.816)与CA-AKI风险增加相关。
  • 验证队列(N=62,986)中GFR<30 mL/min(OR 4.668,95%CI 4.007-5.85)、女性(OR 1.352,95%CI 1.213-1.507)及最大AAA直径>6.9 cm(OR 1.824,95%CI 1.212-1.506)与EVAR术后CA-AKI风险增加相关。

关键数值与推荐

  • CA-AKI定义为肌酐升高>0.5 mg/dL。
  • 预测计算器显示GFR<30 mL/min、女性及最大AAA直径>6.9 cm者EVAR术后CA-AKI风险更高。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 作者指出需前瞻性研究确定该模型的效能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Contrast-associated acute kidney injury (CA-AKI) after endovascular abdominal aortic aneurysm repair (EVAR) is associated with mortality and morbidity. Risk stratification remains a vital component of preoperative evaluation. We sought to generate and validate a preprocedure CA-AKI risk stratification tool for elective EVAR patients. METHODS: We queried the Blue Cross Blue Shield of Michigan Cardiovascular Consortium database for elective EVAR patients and excluded those on dialysis, with a history of renal transplant, death during procedure, and without creatinine measures. Association with CA-AKI (rise in creatinine > 0.5 mg/dL) was tested using mixed-effects logistic regression. Variables associated with CA-AKI were used to generate a predictive model via a single classification tree. The variables selected by the classification tree were then validated by fitting a mixed-effects logistic regression model into the Vascular Quality Initiative dataset. RESULTS: Our derivation cohort included 7,043 patients, 3.5% of whom developed CA-AKI. After multivariate analysis, age (odds ratio [OR] 1.021, 95% confidence interval [CI] 1.004-1.040), female sex (OR 1.393, CI 1.012-1.916), glomerular filtration rate (GFR) < 30 mL/min (OR 5.068, CI 3.255-7.891), current smoking (OR 1.942, CI 1.067-3.535), chronic obstructive pulmonary disease (OR 1.402, CI 1.066-1.843), maximum abdominal aortic aneurysm (AAA) diameter (OR 1.018, CI 1.006-1.029), and presence of iliac artery aneurysm (OR 1.352, CI 1.007-1.816) were associated with increased odds of CA-AKI. Our risk prediction calculator demonstrated that patients with a GFR < 30 mL/min, females, and patients with a maximum AAA diameter of > 6.9 cm are at a higher risk of CA-AKI after EVAR. Using the Vascular Quality Initiative dataset (N = 62,986), we found that GFR < 30 mL/min (OR 4.668, CI 4.007-5.85), female sex (OR 1.352, CI 1.213-1.507), and maximum AAA diameter > 6.9 cm (OR 1.824, CI 1.212-1.506) were associated with an increased risk of CA-AKI after EVAR. CONCLUSIONS: Herein, we present a simple and novel risk assessment tool that can be used preoperatively to identify patients at risk of CA-AKI after EVAR. Patients with a GFR < 30 mL/min, maximum AAA diameter > 6.9 cm, and females who are undergoing EVAR may be at risk for CA-AKI after EVAR. Prospective studies are needed to determine the efficacy of our model.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Braet DJ, Graham NJ, Albright J, et al. A Novel Preoperative Risk Assessment Tool to Identify Patients at Risk of Contrast-Associated Acute Kidney Injury After Endovascular Abdominal Aortic Aneurysm Repair. Ann Vasc Surg. 2023. PMID: 36863491. doi:10.1016/j.avsg.2023.02.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。